<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> of the distal esophagus due to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo>) affects nearly 700,000 people in the United States, and carries a risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> that is 30-125 times that of an age-matched population </plain></SENT>
<SENT sid="1" pm="."><plain>Patients who develop high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> are at greatest risk </plain></SENT>
<SENT sid="2" pm="."><plain>Current recommendations are for endoscopic surveillance to detect <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and to diagnose <z:mp ids='MP_0002038'>carcinoma</z:mp> while it is in an early and possibly treatable stage </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, some authorities recommend esophagectomy for high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, whereas others reserve esophagectomy only for those with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>There are no controlled trials demonstrating that surveillance increases life expectancy in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, endoscopic surveillance of this large group with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> may be costly, and associated with considerable morbidity </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, our objective was to assess the effectiveness and cost-effectiveness of endoscopic surveillance in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>METHODS: Design--Decision analysis using a computer cohort simulation (Markov) </plain></SENT>
<SENT sid="8" pm="."><plain>We examined 12 strategies: (A) no endoscopic surveillance </plain></SENT>
<SENT sid="9" pm="."><plain>Esophagectomy is performed only if <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is detected by biopsy </plain></SENT>
<SENT sid="10" pm="."><plain>(B) no surveillance </plain></SENT>
<SENT sid="11" pm="."><plain>Esophagectomy is performed if high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is detected by biopsy: (C1-C5) surveillance at intervals from 1 to 5 yr, with esophagectomy if <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is diagnosed, and (D1-D5) surveillance at intervals from 1 to 5 yr with esophagectomy if high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is diagnosed </plain></SENT>
<SENT sid="12" pm="."><plain>We measured life expectancy, quality-adjusted life expectancy, and incremental cost-effectiveness ratios for each strategy </plain></SENT>
<SENT sid="13" pm="."><plain>Data Sources--Medline Search and bibliographies of retrieved articles; expert opinion when published data were not available </plain></SENT>
<SENT sid="14" pm="."><plain>RESULTS AND CONCLUSIONS: Annual surveillance with esophagectomy for high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> prevents <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and is the preferred strategy, if only length of life (life expectancy) is considered </plain></SENT>
<SENT sid="15" pm="."><plain>For those who consider both length and quality of life, endoscopy every 2-3 yr will provide the greatest quality-adjusted life expectancy </plain></SENT>
<SENT sid="16" pm="."><plain>When costs are considered, endoscopy every 5 yr also increases life expectancy and has an incremental cost-effectiveness ratio similar to common medical practices </plain></SENT>
<SENT sid="17" pm="."><plain>The cumulative incidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and the quality of life with an esophagectomy had the greatest impact on the decision for surveillance and the optimal surveillance strategy </plain></SENT>
</text></document>